MarketsSectors & Industries

Company	Market Cap	P/E Ratio (TTM)	EPS Growth (5yr)
Abbott Laboratories ABT	58.9B	77.3x	-30.92%
Actavis Inc ACT	16.9B	--	-9.83%
Adamis Pharmaceuticals Corp ADMP	63.5M	--	--
Advanced Medical Isotope Corp ADMD	8.1M	--	--
Akorn Inc AKRX	1.4B	38.2x	--
Allergan Inc AGN	29.2B	26.3x	+17.78%
AmerisourceBergen Corp ABC	12.7B	19.0x	+16.88%
Avvaa World Health Care Products Inc AVVH	1.3M	0.1x	--
Baxter International Inc BAX	39.5B	17.6x	+9.88%
Bayer AG BAYRY	89.3B	27.2x	+0.31%
BioElectronics Corp BIEL	5.3M	--	--
BioLife Solutions Inc BLFS	28.7M	--	--
Bohai Pharmaceuticals Group Inc BOPH	9.5M	0.8x	--
Bristol-Myers Squibb Co BMY	71.9B	49.9x	+12.31%
Cambrex Corp CBM	391.0M	5.9x	--
China BCT Pharmacy Group Inc CNBI	7.6M	0.4x	--
China Medicine Corp CHME	974.3K	--	--
China Sky One Medical Inc CSKI	1.7M	0.1x	--
China YCT International Group Inc CYIG	8.3M	--	--
Columbia Laboratories Inc CBRX	54.3M	8.7x	--
Dr.Reddy's Laboratories Ltd RDY	6.3B	24.3x	+7.43%
Eisai Co Ltd ESALY	12.8B	26.5x	--
Eli Lilly and Co LLY	62.0B	13.2x	+6.21%
EpiCept Corp EPCT	6.2M	--	--
Escalon Medical Corp ESMC	8.5M	--	--
First China Pharmaceutical Group Inc FCPG	7.6M	1.6x	--
Forest Laboratories Inc FRX	10.1B	--	--
Gamma Pharmaceuticals Inc GMPM	197.1K	--	--
Genspera Inc GNSZ	46.3M	--	--
GeoPharma Inc GORXQ	184.9K	--	--
GlaxoSmithKline PLC GSK	128.7B	20.4x	-0.47%
Health Sciences Group Inc HESG	1.9M	--	--
Herbalife Ltd HLF	5.1B	11.5x	+25.19%
IGI Laboratories Inc IG	70.0M	--	--
Impax Laboratories Inc IPXL	1.3B	8.4x	-16.80%
Intellipharmaceutics International Inc IPCI	34.8M	--	--
InVitro International IVRO	333.1K	56.6x	-17.03%
Jiangbo Pharmaceuticals Inc JGBO	178.0K	0.0x	--
Johnson & Johnson JNJ	247.2B	24.0x	+1.22%
Lannett Company Inc LCI	349.7M	31.3x	--
McKesson Corp MCK	26.7B	21.1x	+11.02%
Merck & Co Inc MRK	136.5B	23.0x	+6.08%
Molecular Pharmacology (USA) Ltd MLPH	2.2M	--	--
Mylan Inc MYL	11.9B	20.9x	--
Natural Alternatives International Inc NAII	32.8M	12.5x	+9.54%
Neuro-Hitech Inc NHPI	299.4K	--	--
Nouveau Life Pharmaceuticals Inc NOUV	1.1M	--	--
Novartis AG NVS	201.3B	19.0x	+6.79%
Novelos Therapeutics Inc NVLT	25.3M	--	--
Data delayed 15 minutes.
← Prev12 Next →

The Pharmaceuticals Diversified industry consists of large pharmaceutical companies engaged in the research, development, manufacturing and marketing of drugs. The Pharmaceuticals Diversified industry excludes large drug companies without a research and development operation.

High Dividend EPS Growth Price Discount/BV

Companies that have maintained their dividend in the face of falling share price lead to high dividend yields. Attention should be paid to the sustainability of these future payments. Generally companies with high dividend yields are mature, stable companies.

Company	Dividend Yield
United-Guardian, Inc.	5.02%
GlaxoSmithKline plc (ADR)	4.49%
Merck & Co., Inc.	3.80%
Eli Lilly & Co.	3.56%
Sanofi SA (ADR)	3.46%

K=Thousands, M=Millions, B=Billions, TTM=Trailing 12 Month, MRQ=Most Recent Quarter, FYR=Fiscal Year End, NM=Not Meaningful, NA=Not Available

GAAP = Generally Accepted Accounting Principles used in Financial Statements issued by the company, Non-GAAP = Adjusted Operating Earnings or Revenue used in comparison to Analyst Estimates. Adjustments are typically one-time gains or losses

11:04 AM May 21, 2013

Privacy Policy | Internet Security | Legal

Quotes, News, and Fundamentals provided by

View restrictions

News provided by

MarketsSectors & Industries

Symbol Lookup

Pharmaceuticals - Diversified (US)

Pharmaceuticals - Diversified Companies

Pharmaceuticals - Diversified

Company Strategies